Situation of the Prescription service

The situation of the joint testing of the Prescription service is compiled on this page. Tabulating starts from joint tests completed on 29 April 2016.

Lue yhteistestaukseen osallistumisen edellytyksistä Kanta-palveluiden verkkosivuilta:

Situation of the Prescription service

Open all

Abilita Hälsovård / Abilita Oy Ab

Ongoing joint testings

No ongoing joint testings

Table: Abilita Hälsovård / Abilita Oy Ab accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20102016 / 30.12.2016
Functionality for action on behalf of a minor	20072020 / 14.9.2020

Acute / Vitec Acute Oy

Ongoing joint testings

No ongoing joint testings

Table: Acute / Vitec Acute Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20012016 / 30.11.2016
Forward compatibility of the functionality to act on behalf of a minor	- / 17.2.2020

AssisDent / Entteri Professional Software Oy

Table: AssisDent / Entteri Professional Software Oy ongoing joint testings
Ongoing joint testings	Registration, return date of pre-test cases	Testing between system supplier and Kela	Testing between client test organisation and Kela	Cross-testing
Functionality for action on behalf of a minor	7.10.2020	Ongoing, 23.10.2020	Not tested	Not tested

Table: AssisDent / Entteri Professional Software Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20062016 / 27.12.2016
Forward compatibility of the functionality to act on behalf of a minor	- / 14.9.2020

DomaCare Medi / Invian Oy

Table: DomaCare Medi / Invian Oy ongoing joint testings
Ongoing joint testings	Registration, return date of pre-test cases	Testing between system supplier and Kela	Testing between client test organisation and Kela	Cross-testing
Refusal to share prescription information		Ongoing, 28.4.2021	Not tested	Not tested

Table: DomaCare Medi / Invian Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9	20142017 / 14.3.2017
Functionality for action on behalf of a minor	20032021 / 4.5.2021

DynamicHealth / Tieto Healthcare & Welfare Oy

Ongoing joint testings

No ongoing joint testings

Table: DynamicHealth / Tieto Healthcare & Welfare Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20032016 / 30.12.2016
Forward compatibility of the functionality to act on behalf of a minor	- / 12.3.2020
Functionality for action on behalf of a minor	20122020 / 20.11.2020

Effica / Tieto Healthcare & Welfare Oy

Ongoing joint testings

No ongoing joint testings

Table: Effica / Tieto Healthcare & Welfare Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20032016 / 9.12.2016

Epic / Epic Helsinki Oy

Ongoing joint testings

No ongoing joint testings

Table: Epic / Epic Helsinki Oy accepted joint testing
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.42 and requirement specifications 2.9, Refusal to share prescription information	20022018 / 5.10.2018
Forward compatibility of the functionality to act on behalf of a minor	- / 7.9.2020

eRA / Atostek Oy

Ongoing joint testings

No ongoing joint testings

Table: eRA / Atostek Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20092016 / 29.12.2016
Functionality for action on behalf of a minor	20032020 / 16.3.2020
Functionality for action on behalf of a minor (testing of system changes)	20052020 / 10.8.2020

ESKO / Esko Systems Oy

Ongoing joint testings

No ongoing joint testings

Table: ESKO / Esko Systems Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20022016 / 9.12.2016
Forward compatibility of the functionality to act on behalf of a minor	- / 7.5.2020

GFS / CGI Oy

Ongoing joint testings

No ongoing joint testings

Table: GFS / CGI Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	- / 25.11.2016
Forward compatibility of the functionality to act on behalf of a minor	- / 6.2.2020
Functionality for action on behalf of a minor	20082020 / 22.9.2020

Hilkka / FastROI Oy

Ongoing joint testings

No ongoing joint testings

Table: Hilkka / FastROI Oy a joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9	20082016 / 30.12.2016
Refusal to share prescription information	20012018 / 11.1.2018
Forward compatibility of the functionality to act on behalf of a minor	- / 16.4.2020
Functionality for action on behalf of a minor	20022021 / 12.4.2021

Kelain / Kela

Ongoing joint testings

No ongoing joint testings

Table: Kelain / Kela accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9	20042016 / 9.12.2016
Refusal to share prescription information	20202017 / 1.6.2017
Functionality for action on behalf of a minor	20012020 / 14.1.2020

Lifecare /Tieto Healthcare & Welfare Oy

Table: Lifecare /Tieto Healthcare & Welfare Oy ongoing joint testings
Ongoing joint testings	Registration, return date of pre-test cases	Testing between system supplier and Kela	Testing between client test organisation and Kela	Cross-testing
Functionality for action on behalf of a minor	30.3.2021	Not started	Not tested	Not tested

Table: Lifecare /Tieto Healthcare & Welfare Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20192017 / 11.5.2017
Forward compatibility of the functionality to act on behalf of a minor	- / 14.2.2020

MAXX /Receptum Oy

Ongoing joint testings

No ongoing joint testings

Table: MAXX /Receptum Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20122017 / 11.1.2017
Cross-border prescription	20012019 / 30.9.2019
Functionality for action on behalf of a minor	20062020 / 8.9.2020

Mediatri / Mediconsult Oy

Ongoing joint testings

No ongoing joint testings

Table: Mediatri / Mediconsult Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9	20072016 / 30.12.2016
Refusal to share prescription information	20212017 / 5.6.2017
Forward compatibility of the functionality to act on behalf of a minor	- / 5.5.2020
Functionality for action on behalf of a minor	20042020 / 8.10.2020

Mediresepti / Mediconsult Oy

Ongoing joint testings

No ongoing joint testings

Table: Mediresepti / Mediconsult Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9	20132016 / 30.12.2016
Refusal to share prescription information	20222017 / 4.12.2017
Forward compatibility of the functionality to act on behalf of a minor	- / 8.5.2020
Functionality for action on behalf of a minor	20132020 / 26.11.2020

Navitas / Elisa Appelsiini Oy

Ongoing joint testings

No ongoing joint testings

Table: Navitas / Elisa Appelsiini Oy accepted joint testings
Accepted joint testings	Statement number and date
Refusal to share prescription information	20182017 / 24.2.2017

pd3 / Pharmadata Oy

Ongoing joint testings

No ongoing joint testings

Table: pd3 / Pharmadata Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20172017 / 27.1.2017
Cross-border prescription	20022020 / 20.2.2020
Functionality for action on behalf of a minor	20102020 / 24.9.2020

Pegasos / CGI Oy

Ongoing joint testings

No ongoing joint testings

Table: Pegasos / CGI Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20052016 / 20.12.2016
Forward compatibility of the functionality to act on behalf of a minor	- / 8.4.2020
Functionality for action on behalf of a minor	20012021 / 21.1.2021

Salix / Pharmadata Oy

Ongoing joint testings

No ongoing joint testings

Table: Salix / Pharmadata Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20162017 / 27.1.2017
Cross-border prescription	20022019 / 10.12.2019
Functionality for action on behalf of a minor	20092020 / 24.9.2020

SoftMedic / CGI Oy

Table: SoftMedic / CGI Oy ongoing joint testings
Ongoing joint testings	Registration, return date of pre-test cases	Testing between system supplier and Kela	Testing between client test organisation and Kela	Cross-testing
Functionality for action on behalf of a minor	5.11.2020	Ongoing, 12.11.2020	Not tested	Not tested

Table: SoftMedic / CGI Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	- / 22.11.2016
Forward compatibility of the functionality to act on behalf of a minor	- / 10.9.2020

Uranus / CGI Oy

Table: Uranus / CGI Oy ongoing joint testings
Ongoing joint testings	Registration, return date of pre-test cases	Testing between system supplier and Kela	Testing between client test organisation and Kela	Cross-testing
Functionality for action on behalf of a minor	15.7.2020	Ongoing, 22.4.2021	Not tested	Not tested

Table: Uranus / CGI Oy accepted joint testings
Accepted joint testings	Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information	20152017 / 11.1.2017
Forward compatibility of the functionality to act on behalf of a minor	- / 14.1.2020